Related references
Note: Only part of the references are listed.Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F. A. Vasen et al.
GUT (2013)
Impact of Neonatal Screening and Surveillance for the TP53 R337H Mutation on Early Detection of Childhood Adrenocortical Tumors
Gislaine Custodio et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome Current Status of Clinical Applications and Future Directions
April D. Sorrell et al.
MOLECULAR DIAGNOSIS & THERAPY (2013)
High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort
Gillian Mitchell et al.
PLOS ONE (2013)
Estimating Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer A Cohort Study
Giulia Veronesi et al.
ANNALS OF INTERNAL MEDICINE (2012)
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
Serena Masciari et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Long-term results of screening with magnetic resonance imaging in women with BRCA mutations
K. Passaperuma et al.
BRITISH JOURNAL OF CANCER (2012)
Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
Simona Ognjanovic et al.
CANCER (2012)
Local recurrence of localized soft tissue sarcoma
David J. Biau et al.
CANCER (2012)
Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations
Tobias Rausch et al.
CELL (2012)
The assessment of prognostic factors in surgical treatment of low-grade gliomas: A prospective study
Krzysztof Majchrzak et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2012)
Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden?-A systematic review
Jessica P. Gopie et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Efficacy of a Nationwide Screening Colonoscopy Program for Colorectal Cancer
Christian P. Pox et al.
GASTROENTEROLOGY (2012)
Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals
Marcia Irene Canto et al.
GASTROENTEROLOGY (2012)
Comprehensive molecular characterization of human colon and rectal cancer
Donna M. Muzny et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium
Phuong L. Mai et al.
CANCER GENETICS (2012)
The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
D. Andreou et al.
ANNALS OF ONCOLOGY (2011)
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
Anita V. Mitra et al.
BJU INTERNATIONAL (2011)
Magnetic resonance imaging for lung cancer detection: Experience in a population of more than 10,000 healthy individuals
Nai-Yuan Wu et al.
BMC CANCER (2011)
Psychological impact and acceptability of magnetic resonance imaging and X-ray mammography: the MARIBS Study
J. Hutton et al.
BRITISH JOURNAL OF CANCER (2011)
Association of the Highly Prevalent TP53 R337H Mutation With Pediatric Choroid Plexus Carcinoma and Osteosarcoma in Southeast Brazil
Ana Luiza Seidinger et al.
CANCER (2011)
Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
Philip J. Stephens et al.
CELL (2011)
Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention
Maria Sereno et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53
Alessandra Ferrarini et al.
FAMILIAL CANCER (2011)
Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation
Hans F. A. Vasen et al.
GASTROENTEROLOGY (2011)
Gastric cancer in individuals with Li-Fraumeni syndrome
Serena Masciari et al.
GENETICS IN MEDICINE (2011)
Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome
Chih-Chieh Wu et al.
HUMAN GENETICS (2011)
Clinical Management of Hereditary Breast Cancer Syndromes
Amy S. Clark et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2011)
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families
Jasper I. van der Rhee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study
Anita Villani et al.
LANCET ONCOLOGY (2011)
Malignant transformation of breast fibroadenoma to malignant phyllodes tumor: long-term outcome of 36 malignant phyllodes tumors
Makoto Abe et al.
BREAST CANCER (2011)
Hepatoblastoma: 15-year experience and role of surgical treatment
Suk-Bae Moon et al.
JOURNAL OF THE KOREAN SURGICAL SOCIETY (2011)
Do Surgical Margin and Local Recurrence Influence Survival in Soft Tissue Sarcomas?
Eduardo N. Novais et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2010)
Is Early Diagnosis of Pancreatic Cancer Fiction? Surveillance of Individuals at High Risk for Pancreatic Cancer
F. Harinck et al.
DIGESTIVE DISEASES (2010)
Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
C. R. M. Lammens et al.
FAMILIAL CANCER (2010)
Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning
Christine Maheu et al.
FAMILIAL CANCER (2010)
Prognostic Factors for Survival and Recurrence in Adult Medulloblastoma
A. V. Krauze et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
BRCA1-Associated Breast Cancers Present Differently From BRCA2-Associated and Familial Cases: Long-Term Follow-Up of the Dutch MRISC Screening Study
Adriana J. Rijnsburger et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
Uri Tabori et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes
Marielle W. G. Ruijs et al.
JOURNAL OF MEDICAL GENETICS (2010)
Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer
Sandhya Pruthi et al.
MAYO CLINIC PROCEEDINGS (2010)
P26b Outcome of sentinel node negative patients with primary cutaneous melanoma-prognostic factors and survival probabilities
U. Leiter et al.
MELANOMA RESEARCH (2010)
Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations
Shenying Fang et al.
PLOS ONE (2010)
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome
Steve Heymann et al.
RADIATION ONCOLOGY (2010)
Radiation Doses and Cancer Risks from Breast Imaging Studies
R. Edward Hendrick
RADIOLOGY (2010)
Mouse Models of p53 Functions
Guillermina Lozano
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Neurooncology of Familial Cancer Syndromes
Andreas F. Hottinger et al.
JOURNAL OF CHILD NEUROLOGY (2009)
2009 Version of the Chompret Criteria for Li Fraumeni Syndrome
Julie Tinat et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
TP53 PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis
V. Marcel et al.
JOURNAL OF MEDICAL GENETICS (2009)
Radiation-sensitive genetically susceptible pediatric sub-populations
Ruth A. Kleinerman
PEDIATRIC RADIOLOGY (2009)
F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome
Serena Masciari et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer:: A multicenter, prospective study
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome
Adam Shlien et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Wilms tumour: prognostic factors, staging, therapy and late effects
Sue C. Kaste et al.
PEDIATRIC RADIOLOGY (2008)
Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective
E. R. Woodward et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2007)
Rapid development of post-radiotherapy sarcoma and breast cancer in a patient with a novel germline 'De-Novo' TP53 mutation
A. Salmon et al.
CLINICAL ONCOLOGY (2007)
Sporadic kidney cancer in patients younger than 45
Simon Battisti et al.
PROGRES EN UROLOGIE (2007)
Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age
Marie Trkova et al.
CANCER (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
M. Kriege et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Long-term results of tamoxifen prophylaxis for breast cancer-96-month follow-up of the randomized IBIS-I trial
Jack Cuzick et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome
Uri Tabori et al.
CANCER RESEARCH (2007)
The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes
Marielle W. G. Ruijs et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome
Chih-Chieh Wu et al.
CANCER RESEARCH (2006)
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
G. Bougeard et al.
JOURNAL OF MEDICAL GENETICS (2006)
Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome
P Wong et al.
GASTROENTEROLOGY (2006)
Tamoxifen for the prevention of breast cancer: Current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study
B Fisher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Intracranial necrotizing granuloma caused by Cladophialophora bantiana
S Deb et al.
NEUROLOGY INDIA (2005)
Biology, clinical characteristics, and management of adrenocortical tumors in children
C Rodriguez-Galindo et al.
PEDIATRIC BLOOD & CANCER (2005)
Clinical and outcome characteristics of children with adrenocortical tumors: A report from the international pediatric adrenocortical tumor registry
E Michalkiewicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
GL Bond et al.
CELL (2004)
Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk
SJ Hwang et al.
HUMAN GENETICS (2003)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Germline p53 mutations in a cohort with childhood sarcoma: Sex differences in cancer risk
SJ Hwang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Germline TP53 mutations and Li-Fraumeni syndrome
JM Varley
HUMAN MUTATION (2003)
Update on effects of screening mammography
L Tabár et al.
LANCET (2002)
Prognostic factors in soft tissue sarcomas: a study of 395 patients
PD Stefanovski et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2002)
Is there anticipation in the age at onset of cancer in families with Li-Fraumeni syndrome?
M Trkova et al.
JOURNAL OF HUMAN GENETICS (2002)
Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome
JM Limacher et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
JM Birch et al.
ONCOGENE (2001)
Pretreatment prognostic factors for children with hepatoblastoma results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1
J Brown et al.
EUROPEAN JOURNAL OF CANCER (2000)
Impact of screening survey of gastric cancer on clinicopathological features and survival: Retrospective study at a single institution
H Kubota et al.
SURGERY (2000)
Share Paper
